J b chemicals & pharmaceuticals Financial Statements

JBCHEPHARM Ratio Analysis

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 18.70 15.10 26 4.81
Op profit growth (3) 48.40 73.30 (6.30)
EBIT growth (16) 66.90 83.30 (16)
Net profit growth (14) 64.70 96.60 (25)
Profitability ratios (%)        
OPM 22.40 27.40 21.30 15.50
EBIT margin 21 29.60 20.40 14
Net profit margin 15.90 21.90 15.30 9.82
RoCE 24.40 34.90 23.50 13.10
RoNW 4.89 6.90 4.73 2.47
RoA 4.61 6.47 4.42 2.29
Per share ratios ()        
EPS 50 58 35.30 16.60
Dividend per share 16.50 16.50 11 2
Cash EPS 40.50 49.10 26.60 9.74
Book value per share 276 234 186 172
Valuation ratios        
P/E 31.50 21.60 14.40 18.60
P/CEPS 38.90 25.50 19.10 31.80
P/B 5.70 5.35 2.74 1.79
EV/EBIDTA 20.90 14.40 9.17 10.20
Payout (%)        
Dividend payout -- -- -- 12.10
Tax payout (24) (25) (21) (28)
Liquidity ratios        
Debtor days 71.10 65.60 66.40 73.40
Inventory days 57 55.60 50.20 53.60
Creditor days (41) (46) (38) (35)
Leverage ratios        
Interest coverage (100) (83) (119) (57)
Net debt / equity -- 0.01 -- --
Net debt / op. profit -- 0.03 -- --
Cost breakup ()        
Material costs (35) (34) (36) (38)
Employee costs (18) (17) (18) (18)
Other costs (25) (22) (25) (29)

Invest wise with Expert advice

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp